Anna Semaniakou

Anna Semaniakou, Ph.D. has a diverse range of work experience in various roles and organizations. Anna began their career as a Research Assistant at Dalhousie University in 2015. In 2016, they worked as a Guest Lecturer and Teaching Assistant Tutor at the same university until 2020. Anna then served as a Medical Interpreter at the IWK Health Centre & Queen Elizabeth II Hospital from 2018 to 2020. In 2021, they took on the role of Senior Research Associate at AGADA Biosciences Inc., followed by a position as a Scientist at AGADA Biosciences from 2022 to 2023. Currently, Anna is working as a Clinical Interprofessional Lead - OPOR at Nova Scotia Health Authority.

Anna Semaniakou, Ph.D. completed their education in a field related to medical sciences. Anna earned a Bachelor of Science (BS) degree in Medical Sciences from the University of West Attica. Anna further pursued their studies and earned a Master's Degree in Clinical Biochemistry - Molecular Diagnostics from the Department of Biology at the National & Kapodistrian University of Athens, Greece. Later, they joined the Department of Physiology and Biophysics at the Medical School of Dalhousie University in Halifax, Nova Scotia, where they completed their Doctor of Philosophy (Ph.D.) in Research in Cystic Fibrosis Disease.

In addition to their academic achievements, Anna has obtained several certifications. Anna completed a Certificate of Teaching and Learning at University Level from Dalhousie University in February 2020. Furthermore, they acquired a certification in Leadership Principles from Harvard Business School in July 2023. Anna also holds a Good Clinical Practice (GCP) certification, although the institution and exact timeline for obtaining it are not specified.